Buscar

10/11/2025 An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer
Balado-Simo, P, Morgado-Carrasco, D, Gomez-Armayones, S, Lopez-Ferrer, A, Barco, D, Ferrándiz-Pulido, C, Podlipnik, S. An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer. Journal of Clinical Medicine. 2025; 14(22)DOI:10.3390/jcm14227958. PMID:41302994. IF:2.900(Q1/2D).
01/11/2025 Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort
Jiménez-Sánchez, A, Moreno-Arrones, OM, Béa-Ardebol, S, Mayo-Martínez, F, Pérez-Pastor, G, Torres-Navarro, I, Bonfill-Orti, M, Ruiz-Salas, V, Masferrer, E, Martos-Cabrera, L, Deza, G, Cabrera, RFDM, Feal, C, Turrión-Merino, L, Toll, A, Pérez, CA, Estrada, RB, Yébenes, M, Galiano-Mejías, S, Jiménez-Gallo, D, Ferrandiz-Pulido, C, Florez, A, Hernández-Hernández, N, Rios-Buceta, L, Sanmartín, O, Blanco, CC, Jaka, A, Just-Sarobé, M, Conde-Taboada, A, Arenal, MM, Vargas-Laguna, E, León, IA, Leal, L, Montalvo, SM, Polo, I, Hernández-Marín, B, Soria, A, Delgado-Jiménez, Y, Rodriguez-Jiménez, P. Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2025; 64(11)DOI:10.1111/ijd.17896. PMID:40468572. IF:3.200(Q1/3D).
01/11/2025 Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response
Mansilla-Polo, M, García-Moronta, C, Fernández-Crehuet, P, Garbayo-Salmons, P, Pons-Benavent, M, Aguilar-González, L, Jiménez-Gallo, D, Alcalá-García, R, Martín-Ezquerra, G, Martorell, A, Mahiques-Santos, L, Alfageme-Roldán, F, Escutia-Muñoz, B, Sahuquillo-Torralba, A, Fayos-Gregori, R, Soto-Moreno, A, Sánchez-Gutiérrez, I, Botella-Estrada, R, Vilarrasa, E, Molina-Leyva, A. Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response. Dermatology and Therapy. 2025; 15(11)DOI:10.1007/s13555-025-01521-z. PMID:40866757. IF:4.200(Q1/1D).
01/11/2025 Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance
Papp, KA, Puig, L, Beecker, J, Chandran, V, Claveau, J, Cortes, J, Dutz, J, Hornick, NI, Juergens, RA, Melosky, B, Patel, AB, Sauder, MB, Sehdev, S, Sibaud, V, Snow, SL. Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(11)DOI:10.1111/jdv.20809. PMID:40685883. IF:8.000(Q1/1D).
01/11/2025 [Translated article] Methotrexate-Induced Gouty Arthritis in Psoriatic Patient
Carmona-Rocha, E, Torné, CD, Alonso, AML, Puig, L. [Translated article] Methotrexate-Induced Gouty Arthritis in Psoriatic Patient. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2025.10.010. PMID:41067613. IF:(Q/D).
01/11/2025 [Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?
Fernández, CPH, Borrego, L, Arnau, AMG, Sánchez, TS, Carrillo, JMC, Ninet, VZ, Baldrich, ES, Miquel, FJM, Salvador, JFS, Guijarro, SC, Gilo, AS, García, PM, Triviño, FN, Romero, FT, Serna, MR, Ninot, GM, González, IR, de la Fuente, EG, Nieto, MAP, Guillén, PSP, Pérez, JS, Rodríguez, JJP, Ortega, MEG, Pérez, RG, Doval, IG, Descalzo, MAG. [Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2025.10.016. PMID:41076186. IF:(Q/D).
30/10/2025 Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice
Mateu-Arrom, L, Nogueira, XAV, Puig, L, Spertino, J. Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice. Frontiers In Allergy. 2025; 6DOI:10.3389/falgy.2025.1688464. PMID:41246132. IF:(Q/D).
01/10/2025 Letter to the Editor Regarding: "Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta-Analysis"
Torres, T, Puig, L. Letter to the Editor Regarding: "Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta-Analysis". Dermatology and Therapy. 2025; 15(10)DOI:10.1007/s13555-025-01513-z. PMID:40779225. IF:4.200(Q1/1D).